SOMATIC MUTATION BREAST CANCER (BRCA2)

Clinical trials for SOMATIC MUTATION BREAST CANCER (BRCA2) explained in plain language.

Never miss a new study

Get alerted when new SOMATIC MUTATION BREAST CANCER (BRCA2) trials appear

Sign up with your email to follow new studies for SOMATIC MUTATION BREAST CANCER (BRCA2), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope pill targets weakness in advanced breast cancer

Disease control Ongoing

This study is testing whether a pill called olaparib can help control metastatic breast cancer that has spread in the body. It is for patients whose cancer has a specific weakness—a mutation in certain genes that help repair damaged DNA. The goal is to see if targeting this weakn…

Matched conditions: SOMATIC MUTATION BREAST CANCER (BRCA2)

Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control

Last updated Mar 09, 2026 14:23 UTC

SOMATIC MUTATION BREAST CANCER (BRCA2)

Get alerted when new SOMATIC MUTATION BREAST CANCER (BRCA2) trials appear

New hope pill targets weakness in advanced breast cancer